DAZ4 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, impacting S6K phosphorylation. Decreased S6K activity influences the ribosomal recruitment, which in turn affects DAZ4-regulated translational processes. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Blocks translocation by binding to the 60S ribosomal subunit. Consequently, disrupts protein synthesis, restricting the functional output of DAZ4 in translational regulation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA polymerase, disrupting mRNA synthesis and altering the set of mRNAs that DAZ4 can regulate post-transcriptionally. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Blocks PI3K, which subsequently reduces Akt phosphorylation and mTOR signaling. This change in downstream signaling indirectly affects cellular functions regulated by DAZ4. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, leading to diminished phosphorylation of Akt. Alters mTOR pathway, limiting the scope of cellular processes under DAZ4's regulation. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
Targets mTOR directly, altering the phosphorylation status of 4E-BP1 and S6K. This affects the regulatory parameters defined by DAZ4. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Induces changes in DNA methylation patterns, leading to gene expression modifications that shift the mRNA pool which DAZ4 can regulate. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, thereby affecting stress-induced phosphorylation events. This results in the modulation of cellular functions that would be controlled by DAZ4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Targets JNK, reducing c-Jun phosphorylation and altering AP-1 transcriptional activity. These changes impose limits on mRNAs subject to DAZ4 control. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Blocks CaMKII, affecting calcium signaling. Alters the dynamics of cellular processes that could be modulated by DAZ4. | ||||||